Update – Sandoz Inc. Issues Voluntary Nationwide Recall Expansion of One Additional Lot of Cefazolin for Injection Due to Vials Being Potentially Mislabeled as Penicillin G Potassium for Injection
- Date
- Jul 15, 2025
- Company
- Sandoz, Inc.
- Brand
- Sandoz
- Product
- Cefazolin for Injection, USP, 1 gm vial
- Reason
- Vials incorrectly labelled as Penicillin G Potassium for Injection contain Cefazolin for Injection
- Hazard
- Other
- Source
- FDA
How to identify the product
- (“Sandoz”) is initiating a voluntary nationwide recall expansion of one additional lot of Cefazolin for Injection, USP, 1 gram per vial .
- The lot is being recalled due to a customer complaint indicating that four (4) vials incorrectly labelled as Penicillin G Potassium for Injection, USP , 20 million Units were included in cartons (25 vials per carton) of Cefazolin for Injection, USP 1 gram per vial product.
- Sandoz is notifying its customers by letter and is arranging for return of the recalled product.
- The product being recalled was shipped to select wholesalers for further distribution nationwide.
- Healthcare providers and customers who have this product should immediately stop use of this lot only and contact Sedgwick, the Sandoz Reverse Distributor, directly by phone at (844) 265-7409 or by email at Sandoz5615@sedgwick.com .
- Note: The photos represent images of Lot PG4360.
Where to find the lot number or date code on your package →
Product photos are on the official FDA page.
Facts are taken from the official notice. If anything here differs from it, the official notice is correct.